Ethics declarations Competing interests MV has within the last three years, served as consultant for Lundbeck, Eli Lilly and Johnson & Johnson
Lilly's 2025 guidance of USD 5861 billion implies continued 32% growth momentum, validated by the SURMOUNT-5 Phase 3b head-to-head trial result: Zepbound demonstrated 47% greater relative weight loss compared to Wegovy the most commercially consequential head-to-head data in the obesity market
Its cardiovascular and renal R&D leaders, speaking on Scrips Five Must-Know Things, argued that GLP-1 drugs very limitations create the opening for their pipeline
QUS scans are helpful because the machinery is portable and does not produce harmful radiation
This gives us a clue that there might be a connection, but randomized controlled studies would be the best way to discover whether semaglutide can actually help people quit smoking. The side effects of semaglutide are well understood and include: abdominal pain constipation diarrhea nausea and vomiting These could deter some people from using this drug to quit smoking
These may play a key role in the high increased half life of the Semaglutide-GLP-1R complex (165+ hours, compared to the ~13 hours in the case of Liraglutide)